Kinetic comparisons of amniotic fluid inactive renin and renal renin using synthetic and human renin substrates by Franks, Robert C. et al.
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY 36, 333-339 (1986) 
Kinetic Comparisons of Amniotic Fluid Inactive Renin and Renal 
Renin Using Synthetic and Human Renin Substrates 
ROBERT C. FRANKS,* FRANCIS BODOLA,* ROBERT D. RENTHAL,? 
AND ROBERT H. HAYASHIS 
Departments of *Pediatrics and tBiochemistty, University of Texas Health Science Center, 
San Antonio, Texas 78284-7806. and SDepartment of Obstetrics and Gynecology, 
University of Michigan Medical School. Ann Arbor, Michigan 48109 
Received July 22, 1985 
There are elevated concentrations of inactive renin during pregnancy in maternal 
plasma (l-3), in the fetal circulation (4), and in amniotic fluid (1, 3, 4). Chro- 
matographic differences in the inactive renins isolated from plasma and from 
amniotic fluid are compatible with a maternal renal source of the former and 
fetoplacental origin of the latter (3, 5). Inactive renin is produced by the placenta 
(1, 6) and may be the source of the amniotic fluid inactive renin, comparable to 
other placental polypeptides (7); a fetal renal source is an alternate possibility. 
The role(s) of inactive renin in the respective compartments is currently unknown. 
The maternal plasma concentration of renin substrate is also increased in 
pregnancy (8). Renin substrate is normally present in several component forms 
(9), and not only total concentration but also proportions of the forms may change 
during pregnancy (10-13). Similar changes occur during estrogen treatment. 
During both pregnancy and estrogen treatment, changes in the reaction of 
renin with substrate have been suggested which may be related to the differing 
components (11, 13). Unless activated, inactive renin from kidney and plasma 
does not react with renin substrate (14-16); following activation, however, kinetics 
similar to those with renin have been noted using renin substrate from adult 
controls (15, 16). Comparable studies with amniotic fluid inactive renin and human 
renin substrate have not been reported. 
Although the function of inactive renin in pregnancy is unknown, renin may 
have a role in the regulation of uteroplacental blood flow (17, 18). To evaluate 
a role for inactive renin, we have in the current study determined the kinetics 
of inactive renin isolated from amniotic fluid as reflective of fetoplacental inactive 
renin, with substrate obtained during estrogen treatment as representative of 
maternal substrate. Determinations have also been made following separation of 
the plasma substrate into normal and high molecular weight components and 
with synthetic tetradecapeptide. The kinetics of renal renin with synthetic te- 
tradecapeptide and plasma substrate and its components have also been measured 
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for comparisons to published values and to those determined with amniotic fluid 
inactive renin. 
METHODS AND RESULTS 
Isolation of amniotic fluid inactive renin. Five liters of amniotic fluid, which 
had been collected, pooled, concentrated, and dialyzed as previously described 
(5, 19), was used for the study. Inactive renin was isolated by chromatography 
with, respectively, phenylethylamine-agarose (5), octyl CL-Sepharose (19), pep- 
statin-aminobutyl-agarose (19), and Cibacron blue F3GA (19), with slight mod- 
ification of the column sizes and flow rates previously described. The columns 
were each developed stepwise and fractions from the step having the maximum 
inactive renin to renin ratio were pooled for subsequent chromatography. From 
the final step, the isolate was lyophilized for subsequent determinations of enzyme 
kinetics. Lyophilization and reconstitution did not result in loss of total activity 
or in activation of the inactive renin. 
Elution profiles of renin and inactive renin were determined using trypsin for 
activation of inactive renin and plasma from a nephrectomized ewe for substrate, 
as previously described (5). The angiotensin I (angio I) formed during incubations 
was quantitated by RIA and results were expressed as micrograms or nanograms 
per hour per milliliter. Maximum activation of inactive renin in pooled eluates 
was determined by incubation with five concentrations (l-100 pg/ml) of trypsin. 
Protein was measured by absorbance at 280 nm. 
The five liters of amniotic fluid contained 9 x IO6 ng angio I/hr of inactive 
renin with specific activity of 127 ng angio I/hr/mg protein (-0.00026 GUemg) 
and an inactive renin: renin ratio of 15. The procedure resulted in an overall 
recovery of inactive renin of 8.4% (7.377 x IO5 ng angio I/hr), with specific 
activity of 80,180 ng angio I/hr/mg protein (-0.167 GUmmg), i.e., 642-fold pu- 
rification. The inactive renin: renin ratio was 26, representing -4% activity in 
the final isolate prior to activation. 
Isolation of plasma renin substrate. Fifty milliliters of plasma was obtained 
from a normotensive woman receiving oral contraceptive pills. Ten milliliters 
was used for recovery of pooled renin substrate. The remaining 40 ml was used 
for isolation and further purification of high molecular weight (HMW) and normal 
molecular weight (NMW) components. 
Phenylethylamine-agarose chromatography was used for separation of pooled 
renin substrate (recovery, 84%) from plasma renin and inactive renin, as previously 
described (5). The pooled fractions were dialyzed and lyophilized for use in 
kinetic determinations. 
For the isolation of HMW and NMW renin substrate, the remaining 40 ml of 
plasma was dialyzed and lo-ml fractions were each applied to four columns of 
Sephacryl S-200, as previously described (12). The fractions containing HMW 
substrate, which were free of renin and inactive renin, were pooled, dialyzed, 
and lyophilized for use in kinetic determinations. The fractions containing NMW 
substrate, renin, and inactive renin were further chromatographed on phenyl- 
ethylamine-agarose, as above, for separation of substrate from renin and inactive 
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renin, prior to lyophilization. Analysis of the respective pools revealed 7% of 
the recovered substrate was HMW and 93% was NMW. 
Enzyme-substrate kinetic studies. The studies were performed with aliquots 
from a single ampoule of standard human renal renin (68/356, Division of Biologic 
Standards, London) and with aliquots from a single isolate of amniotic fluid 
inactive renin, studied before and after activation with trypsin. 
Five concentrations of each of four substrates were used for the incubations: 
synthetic tetradecapeptide (3.5-56 PM) (20), pooled plasma renin substrate (0.08- 
2.553 PM), NMW substrate (0.055-1.765 PM), and HMW substrate (0.0174-0.557 
PM). A K, was calculated from duplicate reaction progress curves at the five 
concentrations, using nonlinear regression fits of the Michaelis-Menten equation 
(21). Three K,,, determinations were made for each substrate and the mean + SE 
value for K,,, calculated. The mean values for K,,, were compared using Student’s 
t test. 
Shown in Table 1 are the results (means &SE) of the kinetic studies using 
standard renal renin, amniotic fluid inactive renin, and activated amniotic fluid 
inactive renin with the synthetic and plasma substrates. 
Shown in Table 2 are statistical comparisons of the results from Table 1 for 
plasma substrates. For statistical comparison, P values SO.01 were considered 
to represent significant differences. (With synthetic tetradecapeptide, the values 
of K,,, for standard renal renin, inactive renin, and activated inactive renin were 
not significantly different.) 
Comparisons using values for K,,, of renin, inactive renin, and activated inactive 
renin with pooled, NMW, and HMW plasma renin substrate are shown in the 
upper portion of Table 2. The values for K,,, of renin with the three plasma 
substrates were not different. With inactive renin, the values were significantly 
smaller with pooled (P < 0.01) and HMW (P < 0.001) substrates when compared 
to the NMW form. Using activated inactive renin, the K, with HMW was 
significantly smaller than that for pooled (P < 0.01) and NMW (P < 0.005) 
substrates. 
In the lower portion of Table 2, statistical comparisons of the plasma substrates 
with the respective renins are summarized. Using pooled substrate, the K, for 
TABLE 1 
Values (PM) for Km and V,,,,, (Means + SE) Using Renal Renin Standard and Amniotic Fluid 
Inactive Renin before and after Activation with Synthetic Tetradecapeptide (TDP) and 










L 31.4 f  1.2 0.85 f  0.2 1.6 f  0.2 1.2 2 0.2 
V max 1.9 rf: 0.06 0.3 f  0.05 0.2 2 0.02 0.05 2 0.01 
Km 24.8 f  2.5 1.3 -c 0.3 2.3 f  0.2 0.5 k 0.05 
V max 15.8 It 1.5 1.4 f  0.2 3.1 f  0.3 0.3 f  0.02 
L 34.3 f  2.8 2.4 * 0.4 5.0 * 1.0 1.0 r 0.2 
V max 175.5 t 11.4 25.4 r 3.5 83.7 t 15.8 2.0 * 0.2 
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TABLE 2 
Statistical Comparisons of Values for K,,, from Table 1 for Renal Renin and Amniotic Fluid 
Inactive Renin before and after Activation with Pooled, NMW, and HMW Plasma Renin 
Substrates 
Pooled vs NMW Pooled vs HMW 
Renin P > 0.01 P > 0.05 
Inactive renin P < 0.01 p > 0.01 
Inactive renin” P > 0.01 P < 0.01 
Renin vs IR Renin vs IR” 
Pooled substrate P > 0.05 P < 0.005 
NMW substrate P > 0.01 P < 0.005 
HMW substrate P < 0.005 P > 0.2 
Note. Significant differences (P 6 0.01) are in boldface. 
0 After activation. 
NMW vs HMW 
P > 0.05 
P < 0.001 
P < 0.005 
IR vs IR” 
P > 0.01 
P > 0.01 
P > 0.01 
renin was smaller than that for activated inactive renin (P < 0.005) but not for 
unactivated inactive renin. With NMW substrate, the value for renin was sig- 
nificantly smaller (P < 0.005) than with activated inactive renin. With the HMW 
form, the K,,, for inactive renin was smaller than for standard renin (P < 0.005). 
DISCUSSION 
Amniotic &id inactive renin. In the current study inactive renin has been 
isolated from amniotic fluid following column chromatography on phenylethylamine- 
agarose, octyl-Sepharose, pepstatin-aminobutyl-agarose, and Cibacron blue F3GA. 
We have previously noted differing behavior on phenylethylamine-agarose of 
inactive renin from amniotic fluid and from plasma (5); the further chromatographic 
behavior in this study of amniotic fluid inactive renin was similar to that previously 
reported for plasma and renal inactive renin (14-16). The final isolate was purified 
-642-fold. In contrast to the completely inactive renin described in kidney and 
plasma, however, it had an activity of -4% the amount measured after activation 
and we have been unable to isolate a completely inactive form. The observation 
is similar to that made with inactive renin recovered from cell cultures of chorion 
in which -4-5% of total activity was present before activation (6) and suggests 
that the inactive renin isolated from amniotic fluid by the procedure used here 
may originate in chorion. Although there is a single renin gene in humans, the 
observed differences in activity of renal and chorionic inactive renins might result 
from post-translational events, as previously suggested (22). 
Plasma renin substrate. In this study, renin substrate in plasma from an estrogen- 
treated woman consisted of 93% NMW and 7% HMW. The proportions of the 
respective forms are generally comparable to those reported by others for plasma 
obtained during normotensive pregnancy or estrogen treatment (12). 
Enzyme-substrate kinetics. The kinetics of standard renal renin with synthetic 
and plasma substrates were measured in the current study as a basis for comparison 
to published values. The values for K, were generally comparable to those 
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previously reported for renin with synthetic tetradecapeptide (20), for renin with 
plasma substrate from estrogen-treated subjects (23), and for renin and activated 
renal-plasma inactive renin with plasma substrate from adult volunteers (15, 16). 
An association of both pregnancy-induced and estrogen-induced hypertension 
with the quantity of HMW form of renin substrate has been reported (12, 13) 
and an increased affinity of renin for the HMW substrate suggested (13). In the 
current study, however, the K,,, of renin with pooled, NMW, and HMW substrate 
was not different. The results therefore suggest that if HMW substrate is causally 
related to hypertension, it is via a mechanism other than altered affinity for renin. 
Kinetic studies of amniotic fluid inactive renin have previously been performed 
with heterologous and not with either synthetic or human substrates (1, 24-26), 
and results have not been compared to studies with renal renin. In this study, 
values for K,,, of inactive renin, both before and after activation, were similar 
to the value for renal renin standard with synthetic tetradecapeptide. 
Using plasma renin substrates, the K,,, for amniotic fluid inactive renin was 
significantly smaller (P < 0.01) with pooled than with NMW substrate, a difference 
which could be accounted for by the smaller K,,, (P < 0.001) with HMW vs 
NMW substrate. Although the kinetics of unactivated inactive renin with pooled 
and NMW substrate were not significantly different from those of renal renin, 
the Km of inactive renin with HMW substrate was significantly smaller (P < 
0.005) than that of renin. Following activation of inactive renin, the values for 
K,,, with both the pooled and NMW substrate were significantly larger (P < 0.005) 
than the respective values for renin, while that with HMW substrate was not 
different. 
The current study identifies significant differences between the characteristics 
previously reported for plasma and renal inactive renin and those observed here 
with amniotic fluid inactive renin. The presence of activity prior to activation 
contrasts the amniotic fluid isolate to the “completely inactive” renin from kidney 
and plasma. The unactivated amniotic fluid inactive renin has kinetic constants 
with homologous pooled renin substrate comparable to those reported for renal- 
plasma renin and activated renal-plasma inactive renin. It is noteworthy, however, 
that although the affinity of renin for pooled, NMW, and HMW plasma renin 
substrates was not different, amniotic fluid inactive renin manifests a small but 
statistically significant (P < 0.001) increase in affinity for the HMW component; 
the affinity is also significantly greater (P < 0.005) than that of renin for HMW 
substrate. 
Collectively, the results of the current study can be interpreted as compatible 
with a role, as yet undefined, for fetoplacental inactive renin in renin-angiotensin 
mediated homeostasis of pregnancy. In view of the previously noted association 
of HMW substrate with pregnancy-induced hypertension and the kinetics reported 
herein with fetoplacental inactive renin, a further role in the pathogenesis of 
hypertensive pregnancy may be possible. 
SUMMARY 
Inactive renin has been isolated from pooled amniotic fluid and purified -642- 
fold. Prior to activation the isolates had -4% of the activity found after activation. 
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The observation is similar to that reported for inactive renin from chorionic cell 
culture and suggests a placental origin of amniotic fluid inactive renin. 
Using plasma from an estrogen-treated woman, renin substrate was recovered 
free of renin and inactive renin and a portion was separated into NMW and 
HMW components. The NMW form constituted -93% and the HMW form -7% 
of the renin substrate. 
Amniotic fluid inactive renin was used for determinations of enzyme-substrate 
kinetics with the pooled, NMW, and HMW plasma substrate and tetradecapeptide 
synthetic substrate, and the results were compared to similar determinations 
using standard renal renin. Using synthetic substrate, the kinetics of renal renin 
and amniotic fluid inactive renin before and after activation were similar. The 
kinetics of renal renin with pooled, NMW, and HMW plasma substrate were 
also similar. 
Amniotic fluid inactive renin had a lower K,,, with pooled than with NMW 
substrate, however, which resulted from a significantly smaller K,,, with HMW 
component. Although the affinity constants with pooled substrate were not different 
for renin and inactive renin, the K,,, of inactive renin was significantly less with 
the HMW component of plasma renin substrate. 
The observations are compatible with a role for placental inactive renin in 
normal pregnancy and suggest the possibility of a further role in hypertensive 
pregnancy. 
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